Keeping mind and body healthy through the years

Caromax D-pinitol

D-pinitol helps against age-associated impairment of insulin signaling, lipid metabolism and neurodegeneration-associated mechanisms. These coordinated actions might contribute to prevent insulin resistance, liver steatosis and tau-protein deposition in the brain through unique physiological actions.


Improves insulin response, reducing insulin resistance


Reduces fat deposition, promoting liver health


Reduces tau phosphorylation, guarding against neurodegeneration


High solubility and easy oral administration


  • Reduce insulin needs
  • Protect endocrine pancreas
  • Improve insulin resistance
  • Reduce fat synthesis
  • Reduce liver steatosis
  • Improve liver health

Health areas

Healthy aging

Weight Control

Bone Health

Active Nutrition

Cognitive and
mood support

ideal for

Caromax d-pinitol, the inositol for a healthy aging

Healthy aging is a global demand. Insulin resistance, chronic liver metabolic dysfunction, and neurodegeneration associated to tau-protein deposition are among the main disorders that complicate the natural process of aging. Finding accessible and cost-effective solutions is an unmet clinical need.

Caromax d-pinitol improves carbohydrate and lipid metabolism, and reduce factors promoting neurodegeneration

Caromax d-pinitol is a natural orally active inositol improving insulin resistance by concerted actions on pancreas and the liver. It reduces fat deposition in the liver, helping to avoid steatohepatitis, and reduces the risk of neurodegeneration (including Alzheimer’s Disease). Overall, its consumption is a preventive strategy for chronic disorders accelerating age-associated disabilities.


1. Navarro et al. (2020) conducted a study on Wistar rats to investigate the effects of orally administered D-pinitol from Ceratonia siliqua on pancreas insulin secretion and circulating ghrelin levels.

2. López-Gambero et al. (2020) discussed the potential biomedical uses of inositols in addressing metabolic dysfunction in aging and neurodegenerative diseases..

3. López-Gambero et al. (2021) investigated the association between negative energy balance and metabolic dysfunctions in the hypothalamus of a humanized preclinical model of Alzheimer’s disease, the 5XFAD mouse.

4. Medina-Vera et al. (2021) investigated the activation of the PI3K/Akt signaling pathway in the rat hypothalamus induced by an acute oral administration of D-pinitol.

5. Medina-Vera et al. (2022) investigated the potential of D-pinitol to promote tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism.

6. Navarro et al. (2022) conducted a pharmacokinetic and endocrine study on fasting healthy human volunteers who were given an oral dose of D-pinitol.


The information presented in this page is intended to provide general information on our premium products, their properties and potential applications. It is based on our present state of knowledge and must not be construed as guaranteeing specific properties or approvals of the products described herein or their suitability for any application described. The user is solely responsible for compliance with the existing approvals in the county of use. It is also the sole responsibility of the user to investigate whether existing patents are infringed by the use of the materials described herein. Adequate quality of our products is guaranteed under our General Conditions of Sales. All statements in this page have not been evaluated by the US Food and Drug Administration or EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.


VITAFOODS 2020, the global nutraceutical industry returns to Geneva on 12-14 May 2020. Over the past 22 years Vitafoods Europe...
The INNOVATIVE SME seal recognizes the innovative nature of Euronutra and its participation in numerous projects of public calls for...
A new year has started according to Chinese calendar. It is the Year of the Dog! Euronutra doesn’t want to...